Verici Dx Plc (LSE:VRCI)
FRANKLIN, TN, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, is proud to announce the abstracts highlighting real-world clinical use of its innovative testing technology, Tutivia, have been accepted for presentation at the 2025 World Transplant Congress in San Francisco in August 2025.
Following the recent Medicare coverage approval, clinicians are now sharing compelling














































